Skip to nav Skip to content

IDSA Media Briefing: COVID-19 Vaccine Development

Facebook Twitter LinkedIn Email

A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.

Topical Agenda for February 18 briefing:

  • Vaccine development and approval processes for COVID-19 compared to previous vaccines
  • Evidence and safety data available
  • Ongoing studies of special populations and monitoring
  • Questions from media


  • Dial Hewlett Jr., MD, FIDSA—White Plains, NY
    Fellow—Infectious Diseases Society of America
    Medical Director, Division of Disease Control, Westchester County Department of Health
    Member, National Medical Association COVID-19 Task Force on Vaccines and Therapeutics
  • Matthew Zahn, MD, FIDSA—Santa Ana, CA
    Fellow—Infectious Diseases Society of America
    Medical Director, Division of Epidemiology and Assessment, Orange County Health Care Agency
    Liaison Representative, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention
  • Amanda Jezek (Moderator)
    Senior Vice President, Public Policy & Government Relations—Infectious Diseases Society of America

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.